<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin HL</submitter><funding>Fritz B. Burns Foundation</funding><funding>NIA NIH HHS</funding><funding>Brigham Young University</funding><funding>National Institute on Aging</funding><pagination>2920-2935</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9724711</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(12)</volume><pubmed_abstract>Many of the diseases that plague society today are driven by a loss of protein quality. One method to quantify protein quality is to measure the protein folding stability (PFS). Here, we present a novel mass spectrometry (MS)-based approach for PFS measurement, iodination protein stability assay (IPSA). IPSA quantifies the PFS by tracking the surface-accessibility differences of tyrosine, histidine, methionine, and cysteine under denaturing conditions. Relative to current methods, IPSA increases protein coverage and granularity to track the PFS changes of a protein along its sequence. To our knowledge, this study is the first time the PFS of human serum proteins has been measured in the context of the blood serum (in situ). We show that IPSA can quantify the PFS differences between differe</pubmed_abstract><journal>Journal of proteome research</journal><pubmed_title>Quantifying In Situ Structural Stabilities of Human Blood Plasma Proteins Using a Novel Iodination Protein Stability Assay.</pubmed_title><pmcid>PMC9724711</pmcid><funding_grant_id>R01 AG066874</funding_grant_id><funding_grant_id>R01AG066874</funding_grant_id><pubmed_authors>Haderlie CT</pubmed_authors><pubmed_authors>Berg M</pubmed_authors><pubmed_authors>Price JC</pubmed_authors><pubmed_authors>Moody JD</pubmed_authors><pubmed_authors>Bateman TM</pubmed_authors><pubmed_authors>Zackrison MJ</pubmed_authors><pubmed_authors>James I</pubmed_authors><pubmed_authors>Park JS</pubmed_authors><pubmed_authors>Tseng YJ</pubmed_authors><pubmed_authors>Daley SA</pubmed_authors><pubmed_authors>Lin HL</pubmed_authors><pubmed_authors>Hyer CD</pubmed_authors><pubmed_authors>Zuniga Pina NR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quantifying In Situ Structural Stabilities of Human Blood Plasma Proteins Using a Novel Iodination Protein Stability Assay.</name><description>Many of the diseases that plague society today are driven by a loss of protein quality. One method to quantify protein quality is to measure the protein folding stability (PFS). Here, we present a novel mass spectrometry (MS)-based approach for PFS measurement, iodination protein stability assay (IPSA). IPSA quantifies the PFS by tracking the surface-accessibility differences of tyrosine, histidine, methionine, and cysteine under denaturing conditions. Relative to current methods, IPSA increases protein coverage and granularity to track the PFS changes of a protein along its sequence. To our knowledge, this study is the first time the PFS of human serum proteins has been measured in the context of the blood serum (in situ). We show that IPSA can quantify the PFS differences between differe</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-05-28T02:06:35.122Z</modification><creation>2025-04-06T08:03:36.418Z</creation></dates><accession>S-EPMC9724711</accession><cross_references><pubmed>36356215</pubmed><doi>10.1021/acs.jproteome.2c00323</doi></cross_references></HashMap>